Abstract
Objective: The generally high reported incidence and favorable subsequent salvage rates of islolated vaginal recurrence (IVR) in endometrial carcinoma (EC) are based largely on data generated from low-risk/low-grade EC populations. Although vaginal brachytherapy is a common adjuvant treatment recommendation in high-risk/high-grade EC, the incidence and salvage rates of IVR in this population have not been reported and cannot be assumed to be similar to those for low-risk EC. The purpose of this study was to document the incidence of IVR and subsequent salvage rates in patients with uterine papillary serous carcinoma (UPSC).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
